Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Episode 21 with Dr. Paul Matthews discussing imaging in MS
National MS Society: Patient Management, Care and Rehabilitation Research Grants
Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients.
Mechanisms of action for treatments in multiple sclerosis: Does a heterogeneous disease demand a multi-targeted therapeutic approach?
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.
Mitochondrial DNA Variation and Heteroplasmy in Monozygotic Twins Clinically Discordant for Multiple Sclerosis.
Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-γ and interleukin-4 response.
World Congress of Neurology (WCN) 2015
Episode 25 with actor and science advocate Alan Alda discussing communicating science
Neurovascular and Immuno-Imaging Symposium
FOCIS: Advanced Course in Basic & Clinical Immunology
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
Dimethylfumarate induces apoptosis in human mast cells.
8th Annual Symposium on Glial-Neuronal Interactions
Episode 2 with Dr. Barbara Koppel on recommendations for cannabis in MS
Rapid, sustained and reversible pharmacodynamics of DAC HYP in MS patients supports mechanism of action via modulation of the IL-2 pathway
An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.
Perk Ablation Ameliorates Myelination in S63del-Charcot-Marie-Tooth 1B Neuropathy.
Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells.
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
Defining the Role of Physiotherapy in Palliative Care in Multiple Sclerosis.

Pages